TEK2day FINANCE Open Terminal →

Omnicell, Inc. (OMCL)

NMS · Healthcare · Health Information Services

$37.83 +0.03%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History +26.4% over period
$53$46$39$32$26 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$1.72B
Shares Outstanding
45.5M
P/S (TTM)
1.4x
P/E (TTM)
86.0x
Exchange
NMS
Currency
USD

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue290.6M310.6M314.0M309.9M
Gross Profit127.7M134.5M130.3M140.4M
Operating Income8.1M8.2M415K16.9M
Net Income5.6M5.5M-2.0M11.4M
Diluted EPS$0.12$0.12$-0.05$0.25

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue1.3B1.1B1.1B1.2B
Gross Profit589.0M496.8M471.0M503.4M
Operating Income-2.3M-34.9M337K5.2M
Net Income5.6M-20.4M12.5M2.1M
Diluted EPS$0.12$-0.45$0.27$0.04
Want live quotes, estimates, SEC filings, and CEO analytics for OMCL?
The free TEK2day terminal runs in your browser — type /OMCL to get started.
Open OMCL in the Terminal →